Intracranial tumors can be resected safely in elderly

Intracranial tumors can be resected safely in elderly
Elderly patients do not have poorer short-term outcomes after surgical resection of primary or metastatic intracranial tumors, after accounting for other risk factors, according to research published online Oct. 12 in Cancer.

(HealthDay)—Elderly patients do not have poorer short-term outcomes after surgical resection of primary or metastatic intracranial tumors, after accounting for other risk factors, according to research published online Oct. 12 in Cancer.

Andreea Seicean, M.P.H., of the Case Western Reserve University School of Medicine in Cleveland, and colleagues conducted a prospective study using data from the American College of Surgeons' National -Improvement Project database from 2006 to 2010. Outcomes were assessed for 134 patients aged 75 years and older and 134 -matched patients aged 40 to 74 years of age who underwent craniotomy for resection of .

The researchers found no increase in the odds for poorer short-term outcomes with advanced age. There were no significant differences in minor or major complications between the groups, and no significant differences in return to the operating room or 30-day mortality.

"Contrary to common assumptions, our analysis of a large, prospective, multi-institutional database suggests that advanced age does not predispose individuals undergoing aggressive surgical therapy for primary or metastatic intracranial tumor to increased risk for operative or short-term postoperative morbidity or mortality," the authors write.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Nonoperative approach feasible in advanced colon cancer

Aug 09, 2012

(HealthDay) -- Treating patients with surgically unresectable metastatic colon cancer and an asymptomatic intact primary tumor with bevacizumab and infusional fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6) ...

Recommended for you

Discovery could lead to new cancer treatment

1 hour ago

A team of scientists from the University of Colorado School of Medicine has reported the breakthrough discovery of a process to expand production of stem cells used to treat cancer patients. These findings could have implications ...

Is the HPV vaccine necessary?

7 hours ago

As the school year starts in full swing many parents wonder if their child should receive the HPV vaccine, which is recommended for girls ages 11-26 and boys 11-21. There are a lot of questions and controversy around this ...

User comments